O'Dowd Sarah A 4
4 · Protagonist Therapeutics, Inc · Filed Jan 18, 2023
Insider Transaction Report
Form 4
O'Dowd Sarah A
Director
Transactions
- Award
Stock Option (right to buy)
[F1]2023-01-16+30,000→ 30,000 totalExercise: $12.17Exp: 2033-01-15→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The stock option vests in 12 equal monthly installments following the date of grant.
Signature
/s/ Asif Ali, Attorney-in-Fact for Sarah A. O'Dowd|2023-01-18